Strategic Initiative

Slingshot members are tracking this corporate initiative:

Cellectis (CLLS) Announces Increase in Production of UCART123 T-Cell Therapy Candidate for Acute Myeloid Leukemia (AML) and Other Cancers

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CLLS

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Nov 16, 2016
Projected Implementation:
Q4, 2016
Relevance Tracked Until:
Q4, 2017
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Ucart123, T-cell Therapy Candidate, Acute Myeloid Leukemia, Aml, Other Cancers, Increase In Production